Barclays’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-58,742
| Closed | -$978K | – | 7311 |
|
|
2017
Q3 | $978K | Buy |
58,742
+54,439
| +1,265% | +$885K | ﹤0.01% | 3023 |
|
|
2017
Q2 | $77K | Buy |
4,303
+673
| +19% | +$12.6K | ﹤0.01% | 5094 |
|
|
2017
Q1 | $73K | Buy |
3,630
+177
| +5% | +$4.12K | ﹤0.01% | 5108 |
|
|
2016
Q4 | $86K | Sell |
3,453
-19,852
| -85% | -$469K | ﹤0.01% | 4859 |
|
|
2016
Q3 | $545K | Sell |
23,305
-8,579
| -27% | -$202K | ﹤0.01% | 3143 |
|
|
2016
Q2 | $637K | Sell |
31,884
-55,774
| -64% | -$1.04M | ﹤0.01% | 3001 |
|
|
2016
Q1 | $1.4M | Buy |
87,658
+57,520
| +191% | +$1.18M | ﹤0.01% | 2246 |
|
|
2015
Q4 | $663K | Buy |
30,138
+26,725
| +783% | +$556K | ﹤0.01% | 2964 |
|
|
2015
Q3 | $55K | Buy |
3,413
+2,998
| +722% | +$46.7K | ﹤0.01% | 4977 |
|
|
2015
Q2 | $5K | Sell |
415
-212
| -34% | -$2.82K | ﹤0.01% | 6511 |
|
|
2015
Q1 | $8K | Sell |
627
-563
| -47% | -$6.5K | ﹤0.01% | 6376 |
|
|
2014
Q4 | $12K | Buy |
1,190
+493
| +71% | +$5.84K | ﹤0.01% | 6644 |
|
|
2014
Q3 | $9K | Sell |
697
-10,056
| -94% | -$140K | ﹤0.01% | 6965 |
|
|
2014
Q2 | $139K | Buy |
10,753
+3,066
| +40% | +$40.1K | ﹤0.01% | 5167 |
|
|
2014
Q1 | $92K | Buy |
7,687
+964
| +14% | +$11K | ﹤0.01% | 5529 |
|
|
2013
Q4 | $81K | Buy |
6,723
+30
| +0.4% | +$352 | ﹤0.01% | 5828 |
|
|
2013
Q3 | $67K | Sell |
6,693
-8,151
| -55% | -$76.2K | ﹤0.01% | 5901 |
|
|
2013
Q2 | $133K | Buy |
+14,844
| New | +$150K | ﹤0.01% | 5556 |
|
Barclays's OME Position: Q4 2017 in Review
Barclays sold out of Omega Protein (OME) in Q4 2017, closing a stake of 58,742 shares — an estimated $978K sold.
Barclays first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $1.4M in Q1 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Barclays reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Barclays sold 58,742 Omega Protein shares in Q4 2017, an estimated $978K.
- Barclays first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Barclays's Omega Protein position peaked at $1.4M in Q1 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.